Lysten Global Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Kolhapur, Maharashtra, India, established in 2015.

2015 Kolhapur, Maharashtra, India Active

Last Updated: December 23, 2025

About Lysten Global Pharmaceuticals Private Limited

Lysten Global Pharmaceuticals Private Limited, a active private limited company, was established on 31 July 2015 in Kolhapur, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24239PN2015PTC156013. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.

It upholds a compliant status. Employing 36 professional, Its leadership includes Vikas Lalasaheb Patil (Director), Nitin Parshram Jadhav (Director), Sachin Lalasaheb Patil (Director). Past directors included Sneha Bahubali Borgave, Vikas Lalasaheb Patil, Nitin Parshram Jadhav. It holds no open charges and ₹5.50 M settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at S. No. 235, Flat No. 5, Visava Apartment B Ward, Hanuman Nagar, Kolhapur, Maharashtra, 416007.

Company Details

CIN/LLPIN
U24239PN2015PTC156013
Registration Number
156013
Incorporation Date
31 July 2015
Authorized Capital
₹1.00 M
Paid-Up Capital
₹1.00 M
ROC Code
Roc Pune
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 1.00 M as on 23-12-2025
Paid Up Capital ₹ 1.00 M as on 23-12-2025
Company Age 10 Year, 6 Months
Last Filing with ROC 31 Mar 2023
Satisfied Charges ₹ 5.50 M as on 23-12-2025
Revenue Growth **** -21.40% (FY 2020)
Profit Growth **** 54.79% (FY 2020)
Ebitda **** 53.55% (FY 2020)
Net Worth -14.35% (FY 2020)
Total Assets -13.65% (FY 2020)

Comprehensive Company Insights

Explore comprehensive insights into Lysten Global Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Lysten Global Pharmaceuticals Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Vikas Lalasaheb Patil	Director	13 Jul 2016	Current
Nitin Parshram Jadhav	Director	31 Jul 2015	Current
Sachin Lalasaheb Patil	Director	31 Jul 2015	Current
Vijay Shamrao Patil	Director	04 Nov 2015	Current
Shilpa Nitin Jadhav	Director	21 Nov 2015	Current
Bahubali Kumar Borgave	Director	13 Jul 2016	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	18 Oct 2022	Past
Pramod Abcsdd	Additional Director	30 Dec 2016	Past
Pramod Abcsdd	Director	15 Jul 2021	Past
Pramod Abcsdd	Director	23 Oct 2015	Past
Pramod Abcsdd	Director	15 Jul 2021	Past
Pramod Abcsdd	Additional Director	11 Jan 2016	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Lysten Global Pharmaceuticals.

Lysten Global Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 21.4% decrease. The company also saw a substantial improvement in profitability, with a 54.79% increase in profit. The company's net worth observed a substantial decline by a decrease of 14.35%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-21.40%

*******

Revenue from Operations

*******

-21.40%

*******

Total Assets

*******

-13.65%

*******

Profit or Loss

*******

54.79%

*******

Net Worth

*******

-14.35%

*******

EBITDA

*******

53.55%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Lysten Global Pharmaceuticals?

In 2020, Lysten Global Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹5,500,000.00

Charges Breakdown by Lending Institutions

Indian Bank : 0.55 Cr

Latest Charge Details

Date	Lender	Amount	Status
31 Jan 2017	Indian Bank	₹5.50 M	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Lysten Global Pharmaceuticals?

Lysten Global Pharmaceuticals has a workforce of 36 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Lysten Global Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lysten Global Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Lysten Global Pharmaceuticals

Recent Activity within the Organization

Annual General Meeting

Progress on Lysten Global Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.
30 Sep 2023
Charges

Progress on A charge registered on 31 Jan 2017 via Charge ID 100120028 with Indian Bank was fully satisfied on 16 May 2023. was documented.
16 May 2023
Balance Sheet

Lysten Global Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Pune. was recorded as a recent event.
31 Mar 2023
Charges

Progress on A charge with Indian Bank amounted to Rs. 5.50 M with Charge ID 100120028 was registered on 31 Jan 2017. was documented.
31 Jan 2017
Director Appointment

Progress on Vikas Lalasaheb Patil was appointed as a Director was appointed as a Director on 13 Jul 2016 & has been associated with this company since 9 years 7 months . was documented.
13 Jul 2016
Director Appointment

Progress on Bahubali Kumar Borgave was appointed as a Director was appointed as a Director on 13 Jul 2016 & has been associated with this company since 9 years 7 months . was documented.
13 Jul 2016

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Lysten Global Pharmaceuticals Private Limited?

The CIN of Lysten Global Pharmaceuticals Private Limited is U24239PN2015PTC156013.

Where is Lysten Global Pharmaceuticals Private Limited headquartered?

Lysten Global Pharmaceuticals Private Limited is headquartered at S. No. 235, Flat No. 5, Visava Apartment B Ward, Hanuman Nagar, Kolhapur, Maharashtra, 416007.

When was Lysten Global Pharmaceuticals Private Limited incorporated?

Lysten Global Pharmaceuticals Private Limited was incorporated on 31 July 2015.

Who are the current directors of Lysten Global Pharmaceuticals Private Limited?

The current directors of Lysten Global Pharmaceuticals Private Limited are

What is the primary industry of Lysten Global Pharmaceuticals Private Limited?

The primary industry of Lysten Global Pharmaceuticals Private Limited is Trade.

Is Lysten Global Pharmaceuticals Private Limited a listed company?

Lysten Global Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Lysten Global Pharmaceuticals Private Limited?

The authorized capital of Lysten Global Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.

What is the compliance status of Lysten Global Pharmaceuticals Private Limited?

The compliance status of Lysten Global Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available